Clinical Evaluation of a New Rapid Immunochromatographic Test for Detection of Bordetella Pertussis Antigen

A more rapid and less complicated test is required in clinical settings to diagnose pertussis. We need to detect Bordetella pertussis , which mainly causes pertussis, as early as possible, because pertussis is more likely to become severe in infants, and people around them can easily become the source of infection due to its strong infectivity. Nevertheless, methods that can detect B. pertussis rapidly and efficiently are lacking. Therefore, we developed a new immunochromatographic antigen kit (ICkit) for the early diagnosis of pertussis. The ICkit detects B. pertussis antigens in a nasopharyngeal swab without equipment and provides the result in about 15 min with a simple procedure. Additionally, a prospective study to evaluate the ICkit was conducted in 11 medical institutions, involving 195 cases with suspected pertussis. The sensitivity and specificity of the ICkit were 86.4% (19/22) and 97.1% (168/173), respectively, compared with the real-time polymerase chain reaction (rPCR). The ICkit detected the antigen in both children and adults. Furthermore, the ICkit detected the antigen until the 25th day from the onset of cough, when rPCR detected the antigen. Thus, the ICkit demonstrated a high correlation with rPCR and would help diagnose pertussis more rapidly and efficiently.